Literature DB >> 20350221

Three-year longitudinal study of genotypes of Mycobacterium tuberculosis in a low prevalence population.

Blanca Gallego1, Vitali Sintchenko, Peter Jelfs, Enrico Coiera, Gwendolyn L Gilbert.   

Abstract

OBJECTIVE: To investigate the molecular epidemiology of tuberculosis, temporal and spatial distribution of Mycobacterium tuberculosis isolates and associations between genotypes and clinical characteristics, in a low prevalence population.
METHODS: A total of 930 M. tuberculosis isolates referred to the New South Wales (NSW, Australia) Mycobacterium Reference Laboratory in 2004-2006 were characterised by mycobacterial interspersed repetitive unit (MIRU) and spacer oligonucleotide (spoligo) typing. Associations between genotypes, patient age, disease site and drug resistance were explored and the predictive power of molecular typing was analysed using Bayesian Belief Networks.
RESULTS: Among isolates from 855 NSW residents, there were 287 spoligotypes, 494 MIRU types and 643 unique spoligotype-MIRU type combinations. They formed 73 spoligotype, 104 MIRU type and 76 spoligo-MIRU clusters, most of which contained only two isolates. The majority (87.7%) of spoligotype clusters contained several MIRU profiles and 64.4% of MIRU clusters contained several spoligotypes. The three most common M. tuberculosis clades were Beijing (24.1%), East African Indian (11.8%) and Central Asian (6.5%); 6.9% and 0.7% isolates were resistant to isoniazid and rifampicin, respectively. There was no proof of association between genotype and drug resistance but isoniazid resistance increased independently over time. Given the low rates of genotype clustering, statistical analysis of genotype-phenotype associations was limited. Potential associations were not confirmed by Bayesian classifiers.
CONCLUSIONS: Spoligo and MIRU typing demonstrated low levels of M. tuberculosis clustering in NSW; temporal and spatial changes in M. tuberculosis genotypes reflected migration patterns to Australia. No analytically significant associations between M. tuberculosis genotypes and clinical phenotypes were detected.

Entities:  

Mesh:

Year:  2010        PMID: 20350221     DOI: 10.3109/00313021003631346

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  5 in total

1.  Geo-epidemiologic and molecular characterization to identify social, cultural, and economic factors where targeted tuberculosis control activities can reduce incidence in Maryland, 2004-2010.

Authors:  Catharine Prussing; Carlos Castillo-Salgado; Nancy Baruch; Wendy A Cronin
Journal:  Public Health Rep       Date:  2013-11       Impact factor: 2.792

2.  Temporal dynamics of Mycobacterium tuberculosis genotypes in New South Wales, Australia.

Authors:  Ulziijargal Gurjav; Peter Jelfs; Nadine McCallum; Ben J Marais; Vitali Sintchenko
Journal:  BMC Infect Dis       Date:  2014-08-23       Impact factor: 3.090

3.  Whole Genome Sequencing Demonstrates Limited Transmission within Identified Mycobacterium tuberculosis Clusters in New South Wales, Australia.

Authors:  Ulziijargal Gurjav; Alexander C Outhred; Peter Jelfs; Nadine McCallum; Qinning Wang; Grant A Hill-Cawthorne; Ben J Marais; Vitali Sintchenko
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

4.  Genotyping and spatial analysis of pulmonary tuberculosis and diabetes cases in the state of Veracruz, Mexico.

Authors:  Francles Blanco-Guillot; M Lucía Castañeda-Cediel; Pablo Cruz-Hervert; Leticia Ferreyra-Reyes; Guadalupe Delgado-Sánchez; Elizabeth Ferreira-Guerrero; Rogelio Montero-Campos; Miriam Bobadilla-Del-Valle; Rosa Areli Martínez-Gamboa; Pedro Torres-González; Norma Téllez-Vazquez; Sergio Canizales-Quintero; Mercedes Yanes-Lane; Norma Mongua-Rodríguez; Alfredo Ponce-de-León; José Sifuentes-Osornio; Lourdes García-García
Journal:  PLoS One       Date:  2018-03-13       Impact factor: 3.240

5.  Transmission of Mycobacterium tuberculosis Beijing Strains, Alberta, Canada, 1991-2007.

Authors:  Deanne Langlois-Klassen; Ambikaipakan Senthilselvan; Linda Chui; Dennis Kunimoto; L Duncan Saunders; Dick Menzies; Richard Long
Journal:  Emerg Infect Dis       Date:  2013-05       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.